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Abstract: With ongoing demographic transition, epidemiological transition in India has been 31 
emerged as a growing concern in India. The share of non-communicable disease in total 32 
disease burden has increased from 31 per cent in 1990 to 45 per cent in 2010. This paper 33 
seeks to explore the health scenario of India in the wake of the growing pace of non-34 
communicable diseases like diabetes, hypertension among Indian population using data 35 
from health and morbidity survey of the National Sample Survey Organisation (2004) and 36 
notifies about the resource needed to tackle this growing health risk. Given the share of 37 
private players (70 per cent) in Indian health system, results indicate a higher private 38 
expenditure, mostly out-of-pocket expense, on account of non-communicable diseases. A 39 
timely look into the matter may tackle a more dreadful situation in near future. 40 
 41 
Background:  42 
Through the early and mid-phase of India’s epidemiological transition, the age pattern of 43 
morbidity was overwhelmed with infectious diseases (Murray and Lopez 1997). In the 44 
recent two decades, the prevalence of non-communicable diseases has escalated immensely 45 
in India (Reddy et al. 2005). India’s swift progress through demographic and epidemiological 46 
transition has resulted into a bigger challenge of dual burden of communicable and non-47 
communicable diseases (Jakovljevic and Milovanovic 2015; Yusuf et al. 2001). With the share 48 
of older cohorts increasing relative to that of younger cohorts, infectious and nutritional 49 
disorders are being replaced by chronic, degenerative and mental illnesses as the leading 50 
 causes of morbidity and mortality (Lopez et al. 2006; McKeown 2009). The resulting concern 51 
is not just epidemiological but also economic. Non-communicable diseases, which often go 52 
with long-standing disabilities, have direct economic consequences at households and 53 
community level, both through the expenses on healthcare those divert other expenditure, 54 
but also on levels of income through reduced labor productivity (Abegunde et al. 2007; 55 
United Nations 2015). 56 
Expenditure on health is highly lopsided across the globe, where the developed countries 57 
spend the most on health per person (Getzen and Poullier 1992). The Organisation for 58 
Economic Co-operation and Development (OECD) countries accounted for less than 20 per 59 
cent of the world's population but were responsible for almost 90 per cent of the world's 60 
health spending (WHO 2003). Health expenditure, both in terms of percentage of GDP spent 61 
on health and per capita health expenditure, is much higher in the developed countries than 62 
developing countries. Unlike in economic history of Colonial Age, in recent decade’s global 63 
share of health spending is undergoing gradual but constant change in favor of developing 64 
Third World nations (Jakovljevic and Getzen 2016). Such inevitable and deep changes are 65 
led by top BRICS1 emerging markets (Jakovljevic 2016). In contrast, the ratio of public to 66 
private health expenditure in India is extremely low in India. Further, all the private 67 
expenditure in India (as in some other countries) is almost exclusively represent household’s 68 
out-of-pocket health expenses. According to World Health Organization (WHO 2014), 69 
private share on total healthcare spending in India is as high as 70 per cent, only next to some 70 
poor African countries. In India, 86 per cent of all private expenditure and 72 per cent of total 71 
expenditure are out-of-pocket. These high out-of-pocket spending on health often takes a 72 
                                                          
1 BRICS refers to the association of five major emerging national economies namely Brazil, Russia, India, China and 
South Africa. 
 higher toll on the poor than the rich (Jakovljevic 2015). Poor people in India spend about 15 73 
per cent of their monthly household income for medical treatment (Barik and Desai 2014).  74 
South Asian countries are going through a rapid demographic transition, which often 75 
accompanied by epidemiological transition. In this phase, while communicable diseases are 76 
still pandemic, non-communicable diseases like cardiovascular disease, diabetes, 77 
respiratory diseases, cancer are picking pace. Ghaffar, Reddy and Singhi (2004) pointed out 78 
the growing risk of these disease among South Asian population. The non-communicable 79 
disease in this region have some special feature in addition to those commonly available in 80 
the developing countries. The metabolic syndrome is very common among urban Indians 81 
(Gupta et al. 2001; Ramachandran et al. 2003). The high prevalence of glucose intolerance 82 
and the distinctive dyslipidaemic pattern of reduced concentrations of high density 83 
lipoprotein (HDL) cholesterol and high concentrations of triglycerides characterize the 84 
metabolic profile, and abdominal obesity characterizes the phenotype of the urban adult in 85 
India. Impaired maternal and fetal nutrition, resulting into low birth weight poses a greater 86 
risk of cardiovascular disease in South Asia. While use of tobacco products increases the risk 87 
of cancer in the region, indoor air pollution mostly due to burning wood fuel contributes to 88 
chronic obstructive airway disease (Ghaffar et al. 2004). Barik, Desai and Vanneman (2016)  89 
in their very recent article has argued that richer Indian adults are at greater risk of 90 
developing non-communicable diseases like diabetes, heart disease and high blood pressure 91 
than their poorer counterparts. The report of the Global Burden of Disease reported that the 92 
share of non-communicable disease on the disease burden has increased from 31 per cent in 93 
1990 to 45 per cent in 2010 (Charlson et al. 2015).  94 
 Following the demographic transition, developed western countries have witnessed an 95 
epidemiological transition where the share of non-communicable diseases increased in the 96 
total disease burden.  The non-communicable diseases require a very different health set up 97 
than that is required for communicable diseases. In the present paper, we have tried to 98 
project the future health scenario of India in the wake of demographic transition and 99 
associated health transition. We have estimated the likely scenario of share of communicable 100 
and non-communicable diseases among Indians and required economic resource for 101 
treatment of these maladies. Various countries have developed their National Health 102 
Accounts (NHA) estimates to plan their health budget according to the nature of diseases. 103 
India do not have such a comprehensive NHA estimate. This present study may throw some 104 
light to plan health budget according to the need of the hour and also for future. 105 
Data:  106 
We have used the Morbidity and Healthcare Survey (2004) 60th round, carried out by the 107 
National Sample Survey Organization (NSSO) under the Ministry of Statistics and 108 
Programme Implementation, Government of India as the main data source for the analysis. 109 
The survey was canvassed between January to June, 2004 across the whole of the Indian 110 
Union except i) Leh (Ladakh) and Kargil districts of Jammu and Kashmir, ii) interior villages 111 
of Nagaland situated beyond five kilometres of the bus route and (iii) villages in Andaman 112 
and Nicobar Islands which remain inaccessible throughout the year. It covered 73,868 113 
households of which 47,302 were from rural areas and 26,566 from urban areas. Prevalence 114 
of various morbidity and utilization of healthcare services from public and private sources, 115 
together with the expenditure incurred by the households in this process have been collected 116 
through this survey. The survey collected information if a person was ailing during the last 117 
 15 days prior to the date of survey. The individual sample size was 383,338; of which 118 
195,712 were males and 187,626 females.  119 
The data collected can be summarized in three categories: 120 
 The first category comprises the inpatient healthcare received by the household 121 
members as hospitalized cases during last 365 days. The expenses incurred during 122 
the reference period for treatment (as an inpatient of a hospital) of such ailments and 123 
details of the healthcare finance have been recorded here.  124 
 Irrespective of the hospitalisation status, the second category documents all such 125 
ailments for which the patients were treated during the 15 days prior to the survey.  126 
 The third category includes all ailments suffered during 15 days prior to the date of 127 
survey for which no medical treatment received.  128 
Methodology:  129 
The classification of communicable and non-communicable diseases followed the 130 
classification adopted by World Health Organization (WHO) in Global Burden of Disease 131 
Studies, 2004 (Appendix table 1). The prevalence of any ailment or morbidity has been 132 
defined as the number of persons ailing within the reference period per 1,000 persons 133 
exposed to the risk of the ailment from the same group of population. 134 
The expected change in the share of each category of morbidities has been estimated up to 135 
year 2051. The main assumption behind this projection was that the prevalence rate of each 136 
morbidity category would remain unchanged among all the age groups over times. This is a 137 
very strong assumption, but we did not have a dataset which allows us to examine disease 138 
progression in Indian context. However, this demographic projection would help us to 139 
 foresee the future of Indian epidemiology in the course of demographic transition, the 140 
process already started. Utilization of hospitalization services over the 15-day reference 141 
period was multiplied by 24.33 (i.e. 365/15) to obtain an annualized counterpart of 142 
hospitalizations (after netting out any hospitalizations reported in the 15-day reference 143 
period).   144 
The yearly cost of treatment for communicable and, non-communicable diseases has been 145 
estimated based on per unit cost of treatment for inpatient and outpatient, derived from the 146 
NSSO unit level data. Age-specific hospital-days have been estimated for each disease type. 147 
The average cost of treatment per stay as an inpatient and average duration of stay were 148 
estimated for each disease type to obtain per day average cost of treatment as inpatients, 149 
and multiplying it with the estimated hospital-days provide the annual cost of treatment as 150 
an inpatient. The annual out-of-pocket expenditure as outpatient has also been estimated 151 
following the similar procedure, where out-of-pocket expenditure implies to the expenditure 152 
a household bears after deducting the reimbursement from various healthcare financing 153 
sources. We reached the annual cost of treatment as an outpatient by multiplying the average 154 
cost of treatment with total number of outpatient visit. Age specific inpatient and outpatient 155 
visit has been assumed to capture the effect of the increasing prevalence of non-156 
communicable diseases beyond age 30 years.    157 
Household level out-of-pocket expenses are the major source of healthcare finance in India. 158 
Since the presence of health insurance in India yet to feel, the rest of the health expenditure 159 
are met by the government via its provision of free or subsidized public facilities (Mahal 160 
2005). Thus, we will focus primarily on only these two sources of healthcare financing, 161 
referring to other funding sources when appropriate. Public subsidies for health has been 162 
 estimated as the difference between total expenditure incurred on private facilities 163 
compared to public facilities. The entire analysis has been carried out using appropriate 164 
sample weight available in the dataset. SPSS 18 PASW software was used to analyze the data. 165 
Results:  166 
 167 
Age-specific prevalence of communicable and non-communicable diseases in India, 2004: 168 
In 2004, the prevalence of the communicable and non-communicable disease reported in the 169 
morbidity and health survey was 32 and 48 respectively per thousand Indian population 170 
(Figure 1). We see a dominance of communicable diseases in the very early stages of life, but 171 
with the advancement of the age, the prevalence of non-communicable disease rises 172 
manifold. Though the prevalence of non-communicable diseases rises continuously after age 173 
30 years, it becomes dominant mainly beyond age 45 years and increases gradually with the 174 
increase in age. The prevalence of either communicable or non-communicable disease is 175 
lowest among the population of 15-29 years age group. With the increase in the age, the 176 
prevalence of both communicable and non-communicable disease increases, but the latter 177 
increased at a much faster rate. The prevalence of communicable diseases has been recorded 178 
as 56 and 62 among the old (65+ years) and oldest old (80+ years) people respectively. In 179 
contrast, the prevalence of non-communicable diseases for the same age groups was much 180 
higher, counting 288 and 340 respectively. 181 
[Figure 1 about here] 182 
Non-communicable diseases will take even a higher share among Indian population by 2051: 183 
In India, about half of the disease burden was shared by non-communicable diseases (46.4 184 
per cent) like diabetes, high blood pressure, cardiac condition whereas the share of 185 
 communicable diseases like tuberculosis, malaria was 34 per cent (Figure 2). The share of 186 
communicable diseases was likely to reduce to a-fourth by 2051. At the same time, the share 187 
of non-communicable diseases has been projected to increase to 57.4 per cent. A minimal 188 
decline will be observed in the share of other health condition during the same period. This 189 
shift in share will be observed mainly due to the shift in age distribution of population 190 
towards elderly hood.  191 
[Figure 2 about here] 192 
Health spending on non-communicable diseases and government subsidies: 193 
There was 75 million hospitalization cases during January to June, 2004, out of which 35 194 
million were in government health facilities and 40 million in private facilities (Table 1). We 195 
did not find any remarkable difference in hospitalization due to communicable and non-196 
communicable diseases. Hospitalization in government facilities for communicable diseases 197 
was relatively higher than for non-communicable diseases. People usually rush to private 198 
facilities for hospitalization in case of non-communicable diseases. Beyond age 45 years, the 199 
volume of hospitalized persons due to non-communicable diseases was higher than 200 
communicable diseases in both government and private facilities. Again, the average 201 
duration of stay as an inpatient was much higher for non-communicable diseases than for 202 
communicable diseases (Table 2). Once hospitalized, the average duration of stay in 203 
government facilities was higher than private facilities. The number of hospital days was 204 
higher for non-communicable diseases than communicable diseases in both government as 205 
well as private facilities.  206 
[Table 1 about here] 207 
 The average cost of hospitalization per stay at private facilities (INR 11,552) was much 208 
higher than in public facilities (INR 4,935) for any type of illnesses (Table 2). For non-209 
communicable diseases, average cost per stay as an inpatient was as high as INR 14,377 in 210 
private compared to INR 6,876 in government. The average cost of treatment either as 211 
inpatient or outpatient was higher in private than in public. Each inpatient day accounted 212 
more than three times higher cost in private facilities than in public. In government facilities, 213 
average per day cost of hospitalization for communicable diseases was high among the youth 214 
(age less than 34 years) and the elderly (65 years and above). People of the prime working 215 
age (35-44 years) usually spent more on private facilities when suffered from a 216 
communicable diseases.  217 
[Table 2 about here] 218 
There were nearly 1,740 million outpatient visits during 2004, out of which 380 million were 219 
in government and 1,360 million in private. Outpatient visit was higher in private facilities 220 
than government in all the age groups. Outpatient visit due to communicable diseases was 221 
highest in 0-34 year age group in both government and private facilities but resurged with 222 
age. Outpatient visit for non-communicable diseases increased with age in both types of 223 
health facilities (Table 3). Similar to inpatient care, per visit cost of outpatient treatment was 224 
much higher in private facilities than public facilities. Although the cost of treatment in 225 
private was higher than public, people rushed to private facilities in need. This signifies the 226 
shortfall of public health systems either in reach or in belief or both in Indian context. Cost 227 
of treatment for outpatient care was also higher for non-communicable diseases than 228 
communicable diseases in both types of facilities.  229 
[Table 3 about here] 230 
 Higher cost of treatment among the elderly age group compared to younger age groups has 231 
a clearer implication on future healthcare cost since the proportion of elderly has been 232 
projected to increase substantially with a rising burden of non-communicable diseases. Per 233 
visit out-of-pocket cost of treatment was similar to the total cost of treatment - indicates the 234 
failure of health insurance as a potential tool for effective healthcare finance. This high out-235 
of-pocket health spending leads to the catastrophic level of spending for healthcare and 236 
pushes households to poverty trap (Ghosh 2011; Pal 2012; Peter, Ahuja and Bhandari 2010). 237 
Barman et al. (2010) pointed out that outpatient care was more impoverishing than 238 
inpatient care in urban and rural areas alike. 239 
Government subsidies per inpatient and outpatient day were estimated INR 795 and INR 240 
103 respectively. Subsidies per inpatient day for all types of diseases were higher than 241 
outpatient days. In 2004, Government provided a total subsidy for healthcare of INR 335 242 
billion, out of which INR 294 billion was for inpatient treatment and INR 41 billion for 243 
outpatient treatment in 2004. The majority share of the total government subsidy was 244 
utilized for treatment of non-communicable diseases.  245 
[Table 4 & 5 about here] 246 
Healthcare spending on communicable and non-communicable diseases as a share of Gross 247 
Domestic Product (GDP):  248 
In 2004, 87 per cent of the total healthcare spending in India (approximately INR 100,000 249 
crores) was out-of-pocket spending. India spent 3.35 per cent of the GDP and out-of-pocket 250 
spending on health accounted 2.94 per cent of it. Half of the out-of-pocket spending on 251 
healthcare was on account of the treatment of non-communicable diseases and 30 per cent 252 
was due to communicable diseases during 2004.  253 
 Healthcare expenditure on communicable diseases and non-communicable diseases in India: A 254 
futuristic vision  255 
The healthcare expenditure on the communicable diseases were expected grow rather 256 
slowly than non-communicable diseases. Healthcare expenditure on communicable diseases 257 
in government facilities may rise by about 1.7 times by 2051 than its corresponding figure 258 
in 2006 (Table 6). Whereas expenditure for non-communicable diseases in government 259 
facilities may increase in a much faster rate by 2.5 times within the same time frame. In the 260 
private health facilities, healthcare expenditure on the communicable diseases are expected 261 
to increase from INR 26,243 crores to INR 42,222 crores and on non-communicable diseases 262 
from INR 45,735 crores to 114,413 crores during the same duration. The rise in healthcare 263 
expenditure due to communicable diseases is relatively higher in the first part of the 264 
projection period (2006-26) compared to the second part (2026-51).  265 
[Table 6 about here] 266 
Discussion:  267 
The study provides some insights into the upcoming health requirements in Indian health 268 
system. The age profile of the morbidity indicates a rising risk of non-communicable diseases 269 
as the population ages through demographic transition (Ghaffar et al. 2004; Gupta 2004; 270 
Mohan et al. 2007; Reddy et al. 2005). In spite of a higher cost of treatment, people prefer to 271 
visit private facilities than the public. In India, the private facilities are vast and diverse – 272 
ranging from a person from local medical shop to a super specialty hospital catering to 273 
medical tourists from abroad (Desai et al. 2010). These facilities are available even in small 274 
remote places and offers services as per the convenience of people. The cost of treatment in 275 
these private facilities also varies to a great extent. People frequently prefer to go to a nearby 276 
 private facilities for short term diseases, which requires outpatient visit. Choice among 277 
various private health practitioners arises when the disease is more severe and requires long 278 
term care.  279 
Though government provides subsidized services for public health facilities, people utilize 280 
these facilities mainly for inpatient care. The lower level government facilities like the sub-281 
centres and the primary health centres are not well equipped to serve for severe illnesses. 282 
The higher level and specialized government health facilities are often concentrated in urban 283 
places and travel to these places requires higher level resources and often associated with 284 
wage loss (Desai et al. 2010). India, in the past decade has introduced the Rashtriya Swasthya 285 
Bima Yojana, a health insurance scheme to cover the inpatient care expenses of the poor. It 286 
has also invested on the National Rural Health Mission in 2005, which provides budget 287 
support to expand and improve free primary care in public clinics. While these initiatives 288 
ensure government’s continued effort to improve healthcare services and protect the poor 289 
from health related expenses, these barely promise on the step toward combating non-290 
communicable disease risks.    291 
Conclusion:  292 
The non-communicable diseases require attention at a very early stage and once developed, 293 
medication continues throughout lifetime. Neglecting these diseases incapacitates a person 294 
and may be even life threatening. Ghaffar et al. (2004) attributed the environmental factors 295 
as the major determinants of these health condition. Whereas, they noted sedentary life-296 
style, extreme poverty and inadequate health system as the obstacle to tackle the challenge 297 
if non-communicable diseases in South Asia.  298 
 If India wishes to reap the demographic dividend out of its favourable age-structural 299 
transition, it need to focus on the health of the youth. Creating an enabling atmosphere for 300 
the youth to lead a healthy life-style, create awareness about the ill health effects of smoking 301 
and drinking, regular health check-ups, good dietary intake, are the some among the possible 302 
ways to avoid health risks from non-communicable diseases. In a nutshell, investing on youth 303 
health may result into a higher return in future.   304 
Limitations:  305 
We acknowledge the possible various limitation of the study. The main limitation stands as 306 
the prevalence of morbidity is based on the reported ailments, which is subject to the 307 
knowledge and awareness of a particular morbidity and may differ from estimates based 308 
clinical data.  The study produces the shift in disease share on the basis of pure demographic 309 
profile, which certainly sets a basic level of alarm to Indian health system, but inadequate in 310 
long run. A longitudinal study with clinical investigation will help a more detailed projection. 311 
However, we have tried to pinpoint the short fall of the Indian health system to tackle the 312 
future health problem, which will come along with the ongoing demographic transition.   313 
 Table 1: Total number of person hospitalized, average duration of stay as inpatient and total number of hospital days in government 
and private sector, 2004. 
 
Source: Authors own calculation from NSS 60th round unit level data 
Table 2: Average cost per stay and average cost of hospitalization per day by source of providers, 2004. 
 Average cost per stay as inpatient (INR) 
Per day average cost of hospitalization 
(INR) 
 0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 
CD 2,815 3,079 3,369 3,346 3,034 381 324 299 349 344 
NCD 5,643 8,522 8,030 5,918 6,876 521 556 630 575 575 
OTH 4,463 5,701 5,748 5,321 5,014 438 390 454 440 431 
Govt. 4,071 5,658 5,963 5,120 4,935 444 433 487 492 460 
CD 5,763 10,522 9,877 12,347 8,015 965 1,644 1,278 1,480 1,205 
NCD 10,262 16,263 17,799 14,244 14,377 1,223 1,857 1,967 1,676 1,656 
OTH 10,080 12,278 13,733 14,249 11,718 1,159 1,238 1,384 1,404 1,256 
Pvt. 8,454 13,202 14,613 13,835 11,552 1,120 1,579 1,640 1,567 1,407 
Source: Authors own calculation from NSS 60th round unit level data 
 
Hospitalization - Government (in Million) 
Average duration of stay - Government 
(days) Hospital Days – Government (Million) 
 
0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 
CD 7.81 2.39 2.98 0.85 14.19 7.39 9.49 11.26 9.6 8.81 57.7 22.7 33.6 8.2 122.2 
NCD 3.84 1.79 3.57 1.90 11.69 10.83 15.34 12.75 10.29 11.96 41.5 27.4 45.6 19.5 134.0 
OTHERS 5.00 1.80 1.95 0.59 9.44 10.19 14.62 12.65 12.08 11.64 51.0 26.2 24.7 7.2 109.1 
TOTAL 16.65 5.98 8.51 3.34 35.32 9.18 13.08 12.24 10.4 10.72 152.8 78.2 104.1 34.8 369.9 
 Hospitalization - Private (in Million) Average duration of stay - Private (days) Hospital Days - Private (Million) 
CD 7.30 1.91 2.53 0.89 12.79 5.97 6.4 7.73 8.34 6.65 43.6 12.2 19.5 7.4 82.8 
NCD 5.15 2.50 4.68 2.35 15.43 8.39 8.76 9.05 8.5 8.68 43.2 21.9 42.4 20.0 127.5 
OTHERS 6.00 2.10 2.52 0.91 11.72 8.7 9.92 9.92 10.15 9.33 52.2 20.9 25.0 9.3 107.3 
TOTAL 18.46 6.52 9.72 4.16 39.94 7.55 8.36 8.91 8.83 8.21 139.4 54.5 86.6 36.7 317.2 
 Table 3: Particulars of outpatient care visits, per visit total expenditure and out of pocket expenditure by type of diseases and source 
of providers, 2004. 
  
Total number of visit for outpatient care 
(in millions) 
Per visit cost (INR) for outpatient care Per visit OOP cost (INR) for outpatient care 
  0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 
CD 88.7 13.5 29.0 9.4 140.7 189.2 207.2 222.4 236.7 201.0 184.7 205.4 221.2 236.7 197.7 
NCD 40.7 22.3 52.6 49.2 164.1 223.3 187.0 238.7 208.6 219.2 221.5 183.9 235.3 202.8 215.6 
OTH 38.9 12.8 15.5 11.8 78.7 217.7 406.0 166.1 242.5 241.4 182.0 404.1 164.8 241.7 223.1 
GOVT. 168.3 48.6 97.1 70.4 383.6 204.0 250.2 222.3 218.0 217.1 193.0 247.8 219.9 213.8 210.6 
CD 381.7 57.5 79.1 32.9 550.9 248.8 274.1 401.8 375.6 281.3 248.5 273.2 399.4 372.6 280.5 
NCD 145.3 63.6 180.0 153.2 540.2 321.3 352.6 374.7 339.5 348.2 318.8 351.7 369.1 339.0 345.4 
OTH 142.6 38.7 54.6 32.2 267.8 329.7 330.8 314.8 260.1 318.8 323.4 330.8 311.7 259.4 314.7 
PVT. 669.6 159.8 313.7 218.2 1358.8 281.8 319.1 371.1 333.2 315.3 279.7 318.4 366.7 332.3 313.0 
 Source: Authors own calculation from NSS 60th round unit level data 
 Table 4: Government subsidy per inpatient day and total subsidy for inpatient care by type of disease, 2004. 
 Government subsidy Per inpatient day (INR) Total subsidy in Government (Billion INR) 
 0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 
CD 548 1154 770 896 737 31.6 26.2 25.8 7.3 90.0 
NCD 655 1072 1011 937 892 27.2 29.4 46.0 18.3 119.5 
OTH 644 768 771 699 706 32.8 20.2 19.0 5.0 77.0 
Total 621 985 896 872 795 94.9 77.0 93.3 30.3 294.1 
Source: Authors own calculation from NSS 60th round unit level data 
 
 Table 5: Government subsidy per outpatient visit and total subsidy for outpatient care by type of disease, 2004. 
  Government subsidy per outpatient 
day (INR) 
Outpatient visit in Government 
(Million) 
Total subsidy for outpatient care in 
Government (INR Billion) 
  0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 0-34 35-44 45-64 65+ Total 
CD 63.86 67.75 178.16 135.87 82.74 88.7 13.49 28.97 9.44 140.74 5.66 0.91 5.16 1.28 13.02 
NCD 97.29 167.8 133.78 136.22 129.81 40.7 22.33 52.64 49.18 164.12 3.96 3.75 7.04 6.7 21.45 
OTH 141.4 -73.31 146.86 17.68 91.59 38.9 12.78 15.45 11.75 78.72 5.5 -0.94 2.27 0.21 7.04 
Total 86.75 70.63 146.84 118.51 102.45 168.3 48.6 97.06 70.38 383.58 14.6 3.43 14.25 8.34 40.63 
 Source: National Sample Survey 60 Round, 25.0 sub-round, 2004. 
Table 6: Projected annual healthcare cost (INR Crores) in government and private facilities for communicable and non-
communicable diseases in India. 
 
  2006 2026 2051 
Communicable Diseases   
Government 4,352 5,877 7,364 
Private 26,243 34,634 42,222 
Non-communicable 
Diseases 
     
Government 8,424 13,294 20,722 
Private 45,734 72,535 114,413 
Source: Authors own calculation from NSSO 60th round unit level data 
 
 
  
Appendix Table 1: Classification of communicable and non-communicable diseases 
Communicable 
Disease 
Diarrhoea/ dysentery, Gastritis/gastric or peptic ulcer, Worm 
infestation, Amoebiosis, Hepatitis/Jaundice, Tuberculosis, 
Diseases of kidney/urinary system, Conjunctivitis, Sexually 
transmitted diseases, Malaria, Eruptive, Mumps,     Diphtheria, 
Whooping cough, Fever of unknown origin, Tetanus and 
Filariasis/Elephantiasis   
Non-communicable 
disease 
Heart disease, Hypertension, Respiratory including 
ear/nose/throat ailments, Bronchial asthma, Disorders of joints 
and bones, Prostatic disorders, Gynaechological disorders, 
Neurological disorders, Psychiatric disorders, Glaucoma, Cataract, 
Diseases of skin, Goitre, Diabetes mellitus, Anaemia, Locomotor, 
Visual including blindness (excluding cataract), Speech, Hearing, 
and Diseases of Mouth/Teeth/Gum, Cancer and other tumours,  c)  
Others Under-nutrition, Accidents/Injuries/Burns/ Fractures/Poisoning, 
Other diagnosed ailments and Other undiagnosed ailments. 
 
 
 
 
 
 
 
 References: 
Abegunde, D.O., C.D. Mathers, T. Adam, M. Ortegon, and K. Strong. 2007. "The burden and costs of chronic 
diseases in low-income and middle-income countries." The Lancet 370(9603):1929-1938. 
Barik, D.and S. Desai. 2014. "Determinants Of Private Healthcare Utilisation And Expenditure Patterns In 
India." Pp. 52-64 in India Infrastructure Report 2013|14 The Road to Universal Health Coverage, edited by 
S.B.a.S. Ghosh. New Delhi, India: IDFC Ltd. 
Barik, D., S. Desai, and R. Vanneman. 2016. "Adult Mortality in India: The Health-Wealth Nexus." in 
Population Association of America Annual Conference. Washington DC, USA. 
Charlson, F., H. Erskine, A. Ferrari, H. Gouda, L. Knibbs, J.J. McGrath, R.E. Norman, L. Veerman, and H. 
Whiteford. 2015. "Global, regional, and national incidence, prevalence, and years lived with disability for 
301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the 
Global Burden of Disease Study 2013." The Lancet 386(9995):743-800. 
Desai, S.B., A. Dubey, B.l. Joshi, M. Sen, A. Shariff, and R. Vanneman. 2010. Human Development in India: 
Challenges for a Society in Transition. New Delhi: Oxford University Press. 
Getzen, T.E.and J.-P. Poullier. 1992. "International health spending forecasts: concepts and evaluation." 
Social Science & Medicine 34(9):1057-1068. 
Ghaffar, A., K.S. Reddy, and M. Singhi. 2004. "Burden of non-communicable diseases in South Asia." BMJ 
328(7443):807-810. 
Ghosh, S. 2011. "Catastrophic Payments and Impoverishment due to Out-of-Pocket Health Spending." 
Economic & Political Weekly XLVI 8. 
Gupta, R. 2004. "Trends in hypertension epidemiology in India." Journal of human hypertension 18(2):73-
78. 
Gupta, R., V. Gupta, M. Sarna, S. Bhatnagar, J. Thanvi, V. Sharma, A. Singh, J. Gupta, and V. Kaul. 2001. 
"Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-
2." Indian heart journal 54(1):59-66. 
Jakovljevic, M.and T.E. Getzen. 2016. "Growth of global health spending share in low and middle income 
countries." Frontiers in pharmacology 7. 
Jakovljevic, M.B. 2015. "BRIC’s growing share of global health spending and their diverging pathways." 
Frontiers in Public Health 3:135. 
Jakovljevic, M.B.and O. Milovanovic. 2015. "Growing burden of non-communicable diseases in the 
emerging health markets: the case of BRICS." Frontiers in Public Health 3:65. 
Jakovljevic, M.M. 2016. "Comparison of historical medical spending patterns among the BRICS and G7." 
Journal of Medical Economics 19(1):70-76. 
Lopez, A.D., C.D. Mathers, M. Ezzati, D.T. Jamison, and C.J. Murray. 2006. "Global and regional burden of 
disease and risk factors, 2001: systematic analysis of population health data." The Lancet 367(9524):1747-
1757. 
Mahal, A. 2005. "Policy implications of the distribution of public subsidies on health and education: The 
case of Karnataka, India." Comparative Education Review 49(4):552-574. 
McKeown, R.E. 2009. "The epidemiologic transition: changing patterns of mortality and population 
dynamics." American journal of lifestyle medicine. 
Mohan, V., S. Sandeep, R. Deepa, B. Shah, and C. Varghese. 2007. "Epidemiology of type 2 diabetes: Indian 
scenario." Indian journal of medical research 125(3):217. 
Murray, C.J.and A.D. Lopez. 1997. "Alternative projections of mortality and disability by cause 1990–2020: 
Global Burden of Disease Study." The Lancet 349(9064):1498-1504. 
Pal, R. 2012. "Measuring incidence of catastrophic out-of-pocket health expenditure: with application to 
India." International Journal of Health Care Finance and Economics 12(1):63-85. 
Peter, B., R. Ahuja, and L. Bhandari. 2010. "The Impoverishing Effect of Healthcare Payments in India: New 
Methodology and Findings." Economic and Political Weekly XLV(16):7. 
 Ramachandran, A., C. Snehalatha, K. Satyavani, S. Sivasankari, and V. Vijay. 2003. "Metabolic syndrome in 
urban Asian Indian adults—a population study using modified ATP III criteria." Diabetes research and 
clinical practice 60(3):199-204. 
Reddy, K.S., B. Shah, C. Varghese, and A. Ramadoss. 2005. "Responding to the threat of chronic diseases 
in India." The Lancet 366(9498):1744-1749. 
United Nations, D.o.E.a.S.A., Population Division. 2015. " World Population Prospects: The 2015 Revision, 
Key Findings and Advance Tables." 
WHO. 2003. The world health report 2003: shaping the future: World Health Organization. 
—. 2014. World health statistics 2014: World Health Organization. 
Yusuf, S., S. Reddy, S. Ôunpuu, and S. Anand. 2001. "Global burden of cardiovascular diseases part I: 
general considerations, the epidemiologic transition, risk factors, and impact of urbanization." Circulation 
104(22):2746-2753. 
i 
i Acknowledgement: The earlier version of this paper was presented at the annual conference of the Population 
Association of America, held during 1-4 May, 2014 in Boston, MA. We acknowledge the suggestions received from 
some the participants to improve the quality of the paper.  
                                                          
